Biotech Co. Human Genome Rejects $2.6B Bid From GSK – site.law360.com

April 19, 2012 Posted By: Leave a comment
Law360, New York (April 19, 2012, 1:24 PM ET) -- Gene-targeting drug developer Human Genome Sciences Inc. on Thursday rejected an unsolicited $2.59 billion bid from GlaxoSmithKline PLC, but a cozy relationship between the companies could still result in a ...
Subscribe to LegalLaw247.Com Newsletter

Leave a Reply

Your email address will not be published. Required fields are marked *

*

CAPTCHA Image

*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>